Live Breaking News & Updates on Phocas Financial

Stay updated with breaking news from Phocas financial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Avidity Partners Management LP Has $89.94 Million Holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Avidity Partners Management LP grew its position in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC – Free Report) by 61.8% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,156,692 shares of the company’s stock after acquiring an additional 441,692 […] ....

United States , Puerto Rico , Exchange Commission , Royal Bank , Acadia Healthcare Company Inc , Phocas Financial Corp , Campbell Co Investment Adviser , Avidity Partners Management , Acadia Healthcare Company , Free Report , Partners Management , Acadia Healthcare , State Employees Retirement System , Partners Asset Management , Phocas Financial , Healthcare Stock Down , Healthcare Company , Get Free Report , Acadia Healthcare Daily ,

Veeco Instruments (NASDAQ:VECO) Earns Outperform Rating from Oppenheimer

Veeco Instruments (NASDAQ:VECO) Earns Outperform Rating from Oppenheimer
tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.

United States , Adrian Devasahayam , Veeco Instruments , Vanguard Group Inc , Needham Company , Manufacturers Life Insurance Company , Veeco Instruments Inc , Blue Grotto Capital , Phocas Financial Corp , Goldman Sachs Group , Get Free Report , Grotto Capital , Phocas Financial , Instruments Inc , Middle East , Veeco Instruments Daily ,

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) CEO Stephen Davis Sells 11,427 Shares of Stock

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) CEO Stephen Davis sold 11,427 shares of the business’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $16.94, for a total transaction of $193,573.38. Following the sale, the chief executive officer now directly owns 155,231 shares of the […] ....

United States , Stephen Davis , Phocas Financial Corp , Empire Life Investments Inc , Royal Bank , Pharmaceuticals Inc , Pharmaceuticals Stock Down , Pharmaceuticals Company Profile , Quest Partners , Morgan Stanley , Cantor Fitzgerald , Franklin Resources Inc , Acadia Pharmaceuticals Inc , Pharmaceuticals Daily , Get Free Report , Stock Down , Life Investments , Phocas Financial ,